ArticleSurgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery2026
Impact of preoperative and postoperative anti-obesity medications on early postoperative body mass index reduction after sleeve gastrectomy in pediatrics.
Article in Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
backgroundAntio-besity medications (OMs) are increasingly used in youth before and after metabolic and bariatric surgery (MBS), but their impact on surgical outcomes remains unclear.
objectivesThis study examined whether perioperative OM exposure affects early postoperative body mass index (BMI) reduction in youth undergoing sleeve gastrectomy (SG), and whether presurgery OM response influences outcomes.
settingPediatric MBS program at a free-standing, tertiary care, safety-net children's hospital.
methodsA retrospective review was conducted of youth (age 7-21) who underwent SG from November 2023 to March 2025. Youth were stratified based on perioperative OM use, defined as OM use for at least 3 months prior to surgery (n = 74). Among these 74 youth, 47 (64%) resumed OM use within 6 months postoperatively. This group was compared to youth with no OM exposure either before or after SG (n = 20). Primary outcomes were percent change in BMI (%BMI), percent excess BMI loss (% EBMIL), and percent total weight loss (% TWL) at 1-, 2-, and 3-months postsurgery. Secondary outcomes included 90-day postoperative safety and eating behavior changes. A secondary analysis compared "high responders" to OM (>5% BMI loss pre-SG, n = 23) versus "low responders" (≤5%, n = 51). Mixed-effects models adjusted for BMI at consult, age, and time between medical weight management and surgery date.
resultsAmong 94 youth (mean age 16.5 ± 2.3 years; BMI 50.1 ± 9.7 kg/m
conclusionsPerioperative OM use alone did not predict short-term weight loss after SG, but high OM responders before surgery had greater benefit. Further research is needed to optimize OM-MBS integration in youth.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.